000 | 01781 a2200493 4500 | ||
---|---|---|---|
005 | 20250515053937.0 | ||
264 | 0 | _c20070913 | |
008 | 200709s 0 0 eng d | ||
022 | _a0007-0920 | ||
024 | 7 |
_a10.1038/sj.bjc.6603579 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aForget, M-A | |
245 | 0 | 0 |
_aThe Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. _h[electronic resource] |
260 |
_bBritish journal of cancer _cFeb 2007 |
||
300 |
_a646-53 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xbiosynthesis |
650 | 0 | 4 |
_aKidney Neoplasms _xgenetics |
650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanoma _xgenetics |
650 | 0 | 4 |
_aPlacenta _xmetabolism |
650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 |
_aReverse Transcriptase Polymerase Chain Reaction _xmethods |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aTurcotte, S | |
700 | 1 | _aBeauseigle, D | |
700 | 1 | _aGodin-Ethier, J | |
700 | 1 | _aPelletier, S | |
700 | 1 | _aMartin, J | |
700 | 1 | _aTanguay, S | |
700 | 1 | _aLapointe, R | |
773 | 0 |
_tBritish journal of cancer _gvol. 96 _gno. 4 _gp. 646-53 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6603579 _zAvailable from publisher's website |
999 |
_c16808499 _d16808499 |